Adviti Naik
-
- Cancer Immunotherapy and Biomarkers 5
- Cancer Cells and Metastasis 4
- PARP inhibition in cancer therapy 3
-
- Immunotherapy and Immune Responses 5
- Immune Cell Function and Interaction 4
-
- Angiogenesis and VEGF in Cancer 3
- DNA Repair Mechanisms 2
-
- Liver Disease Diagnosis and Treatment 3
- Co-authors
- Julie DecockDamjana RozmanRok KoširArta M. MonjazebRemy ThomasUlrich M. ZangerSirin A. AdhamMahmoud W. Yaish
- Cited by
- Cancer ResearchOncologyImmunology
- Journals
- SHILAP Revista de lepidopterología (1 paper)Scientific Reports (1 paper)Frontiers in Immunology (1 paper)
In The Last Decade
Adviti Naik
22 papers receiving 544 citations
Peers
Comparison fields: 5 of 78
- Cancer Research 127
- Oncology 206
- Immunology 115
- Molecular Biology 276
- Epidemiology 124
Countries citing papers authored by Adviti Naik
This map shows the geographic impact of Adviti Naik's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Adviti Naik with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Adviti Naik more than expected).
Fields of papers citing papers by Adviti Naik
This network shows the impact of papers produced by Adviti Naik. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Adviti Naik. The network helps show where Adviti Naik may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Adviti Naik, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 2 | |
| 2 | 2024 | 7 | |
| 3 | 2024 | 1 | |
| 4 | 2023 | 9 | |
| 5 | 2022 | 7 | |
| 6 | 2021 | 25 | |
| 7 | 2021 | 19 | |
| 8 | 2020 | 22 | |
| 9 | 2020 | 47 | |
| 10 | 2019 | 51 | |
| 11 | 2019 | 12 | |
| 12 | 2019 | 66 | |
| 13 | 2018 | 47 | |
| 14 | 2017 | 40 | |
| 15 | 2014 | 16 | |
| 16 | 2013 | 53 | |
| 17 | 2013 | 79 | |
| 18 | 2012 | 1 | |
| 19 | Biochemical Mathematical Modeling with Modelica and the BioChem Library | 2007 | 1 |
| 20 | 1999 | 1 |
About Adviti Naik
Adviti Naik is a scholar working on Oncology, Immunology and Pharmacology, having authored 22 papers that have together received 547 indexed citations. Recurring topics across this work include Cancer Immunotherapy and Biomarkers (5 papers), Immunotherapy and Immune Responses (5 papers), Immune Cell Function and Interaction (4 papers), Cancer Cells and Metastasis (4 papers), Liver Disease Diagnosis and Treatment (3 papers), Angiogenesis and VEGF in Cancer (3 papers), PARP inhibition in cancer therapy (3 papers) and DNA Repair Mechanisms (2 papers). The work is most often cited by research in Cancer Research (127 citations), Oncology (206 citations) and Immunology (115 citations). Adviti Naik has collaborated with scholars based in Qatar, Slovenia and Oman. Frequent co-authors include Julie Decock, Damjana Rozman, Rok Košir, Arta M. Monjazeb, Remy Thomas, Ulrich M. Zanger, Sirin A. Adham, Mahmoud W. Yaish, Prasanna R. Kolatkar and Mansour Al‐Moundhri. Their work appears in journals such as SHILAP Revista de lepidopterología, Scientific Reports and Frontiers in Immunology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.